Markers of progression in early-stage invasive breast cancer: a predictive immunohistochemical panel algorithm for distant recurrence risk stratification

被引:0
|
作者
Mohammed A. Aleskandarany
D. Soria
A. R. Green
C. Nolan
Maria Diez-Rodriguez
I. O. Ellis
E. A. Rakha
机构
[1] University of Nottingham,Molecular Pathology Research Unit, Division of Cancer and Stem Cells, School of Medicine
[2] Menofia Faculty of Medicine,Pathology Department
[3] University of Nottingham,Advanced Data Analysis Centre, School of Computer Science
来源
关键词
Breast cancer; Immunohistochemistry; Metastasis; Risk stratification algorithm;
D O I
暂无
中图分类号
学科分类号
摘要
Accurate distant metastasis (DM) prediction is critical for risk stratification and effective treatment decisions in breast cancer (BC). Many prognostic markers/models based on tissue marker studies are continually emerging using conventional statistical approaches analysing complex/dimensional data association with DM/poor prognosis. However, few of them have fulfilled satisfactory evidences for clinical application. This study aimed at building DM risk assessment algorithm for BC patients. A well-characterised series of early invasive primary operable BC (n = 1902), with immunohistochemical expression of a panel of biomarkers (n = 31) formed the material of this study. Decision tree algorithm was computed using WEKA software, utilising quantitative biomarkers’ expression and the absence/presence of distant metastases. Fifteen biomarkers were significantly associated with DM, with six temporal subgroups characterised based on time to development of DM ranging from <1 to >15 years of follow-up. Of these 15 biomarkers, 10 had a significant expression pattern where Ki67LI, HER2, p53, N-cadherin, P-cadherin, PIK3CA and TOMM34 showed significantly higher expressions with earlier development of DM. In contrast, higher expressions of ER, PR and BCL2 were associated with delayed occurrence of DM. DM prediction algorithm was built utilising cases informative for the 15 significant markers. Four risk groups of patients were characterised. Three markers p53, HER2 and BCL2 predicted the probability of DM, based on software-generated cut-offs, with a precision rate of 81.1 % for positive predictive value and 77.3 %, for the negative predictive value. This algorithm reiterates the reported prognostic values of these three markers and underscores their central biological role in BC progression. Further independent validation of this pruned panel of biomarkers is therefore warranted.
引用
收藏
页码:325 / 333
页数:8
相关论文
共 50 条
  • [1] Markers of progression in early-stage invasive breast cancer: a predictive immunohistochemical panel algorithm for distant recurrence risk stratification
    Aleskandarany, Mohammed A.
    Soria, D.
    Green, A. R.
    Nolan, C.
    Diez-Rodriguez, Maria
    Ellis, I. O.
    Rakha, E. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 151 (02) : 325 - 333
  • [2] Prediction of early and late distant recurrence in early-stage breast cancer with Breast Cancer Index
    Zhang, Yi
    Schnabel, Catherine A.
    Schroeder, Brock
    Jerevall, Piiha-Lotta
    Jankowitz, Rachel Catherine
    Stal, Olle
    Brufsky, Adam
    Sgroi, Dennis
    Erlander, Mark G.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma
    Sureerat Padthaisong
    Malinee Thanee
    Nisana Namwat
    Jutarop Phetcharaburanin
    Poramate Klanrit
    Narong Khuntikeo
    Attapol Titapun
    Sakkarn Sungkhamanon
    Hideyuki Saya
    Watcharin Loilome
    Journal of Translational Medicine, 18
  • [4] Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma
    Padthaisong, Sureerat
    Thanee, Malinee
    Namwat, Nisana
    Phetcharaburanin, Jutarop
    Klanrit, Poramate
    Khuntikeo, Narong
    Titapun, Attapol
    Sungkhamanon, Sakkarn
    Saya, Hideyuki
    Loilome, Watcharin
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [5] REVIEW OF TRADITIONAL PROGNOSTIC AND PREDICTIVE MARKERS IN EARLY-STAGE BREAST CANCER
    Plun-Favreau, J.
    Luthman, S.
    Svedman, C.
    Mesterton, J.
    BREAST, 2013, 22 : S58 - S58
  • [6] Prediction of Local Recurrence, Distant Metastases, and Death After Breast-Conserving Therapy in Early-Stage Invasive Breast Cancer Using a Five-Biomarker Panel
    Millar, Ewan K. A.
    Graham, Peter H.
    O'Toole, Sandra A.
    McNeil, Catriona M.
    Browne, Lois
    Morey, Adrienne L.
    Eggleton, Sarah
    Beretov, Julia
    Theocharous, Constantine
    Capp, Anne
    Nasser, Elias
    Kearsley, John H.
    Delaney, Geoff
    Papadatos, George
    Fox, Christopher
    Sutherland, Robert L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) : 4701 - 4708
  • [7] A predictive model for prognostic risk stratification of early-stage NSCLC based on clinicopathological and miRNA panel
    Ying, Lisha
    Lu, Tingting
    Tian, Yiping
    Guo, Hui
    Wu, Conghui
    Xu, Chen
    Jin, Jiaoyue
    Zhu, Rui
    Liu, Pan
    Yang, Ying
    Yang, Chaodan
    Ding, Wenyu
    Xu, Chenyang
    Huang, Minran
    Ma, Zhengxiao
    Zhang, Yuting
    Zhuo, Yue
    Zou, Ruiyang
    Su, Dan
    LUNG CANCER, 2024, 195
  • [8] Survival in Early-Stage Invasive Breast Cancer
    Baker, Jennifer L.
    Hosseini, Ava
    Blue, Michael S.
    Vera, David R.
    Wallace, Anne M.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : 25 - 26
  • [9] Breast Cancer Index Identifies Early-Stage Estrogen Receptor-Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence
    Zhang, Yi
    Schnabel, Catherine A.
    Schroeder, Brock E.
    Jerevall, Piiha-Lotta
    Jankowitz, Rachel C.
    Fornander, Tommy
    Stal, Olle
    Brufsky, Adam M.
    Sgroi, Dennis
    Erlander, Mark G.
    CLINICAL CANCER RESEARCH, 2013, 19 (15) : 4196 - 4205
  • [10] Accuracy of Perceived Risk of Recurrence Among Patients With Early-Stage Breast Cancer
    Liu, Ying
    Perez, Maria
    Aft, Rebecca L.
    Massman, Kerry
    Robinson, Erica
    Myles, Stephanie
    Schootman, Mario
    Gillanders, William E.
    Jeffe, Donna B.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (03) : 675 - 680